慢性肾脏病实用电子表型的开发与验证
研究开发并验证了一种基于电子健康记录的慢性肾脏病实用电子表型。该表型在五个医疗机构的成人中实施,通过盲法病历审查验证,识别CKD的敏感性、特异性和诊断准确性分别为99%、99%和98%,透析分别为94%和89%,移植分别为97%和91%。
要点
- 电子表型定义:最近eGFR<60且90天前至少一次<60,或最近UACR≥30且90天前至少一次阳性。
- 无UACR时,尿白蛋白试纸阴性视为A1,微量至1+视为A2,≥2+视为A3。
- 该表型识别CKD敏感性99%、特异性99%、准确性98%。
核心结论
- 该CKD电子表型为基于电子健康记录识别可能CKD患者提供了实用且准确的方法。
研究设计与样本
- 由专家工作组开发,在五个医疗机构的成人住院或门诊患者中实施。
- 在四个站点比较同日UACR与尿白蛋白试纸结果以确定试纸切点。
- 在四个站点随机抽取从无CKD至ESKD的患者样本,通过盲法病历审查进行验证。
主要发现
- CKD电子表型的敏感性、特异性和诊断准确性分别为99%、99%和98%。
- 透析的敏感性为94%,特异性为89%。
- 移植的敏感性为97%,特异性为91%。
关键数值与推荐
- CKD电子表型定义为最近eGFR<60 ml/min per 1.73 m2且90天前至少一次值<60 ml/min per 1.73 m2,和/或最近UACR≥30 mg/g且90天前至少一次阳性值。
- 透析和移植通过诊断代码识别。
- 无UACR时,敏感CKD定义将尿白蛋白试纸阴性视为正常至轻度增高(KDIGO A1),微量至1+视为中度增高(KDIGO A2),≥2+视为重度增高(KDIGO A3)。
临床怎么用
- 可利用电子健康记录数据自动化识别可能CKD患者,支持研究和临床管理。
- 在缺乏UACR时,可依据尿白蛋白试纸结果按KDIGO分级进行CKD识别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Poor identification of individuals with CKD is a major barrier to research and appropriate clinical management of the disease. We aimed to develop and validate a pragmatic electronic (e-) phenotype to identify patients likely to have CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The e-phenotype was developed by an expert working group and implemented among adults receiving in- or outpatient care at five healthcare organizations. To determine urine albumin (UA) dipstick cutoffs for CKD to enable use in the e-phenotype when lacking urine albumin-to-creatinine ratio (UACR), we compared same day UACR and UA results at four sites. A sample of patients, spanning no CKD to ESKD, was randomly selected at four sites for validation via blinded chart review. RESULTS: The CKD e-phenotype was defined as most recent eGFR <60 ml/min per 1.73 m2 with at least one value <60 ml/min per 1.73 m2 >90 days prior and/or a UACR of ≥30 mg/g in the most recent test with at least one positive value >90 days prior. Dialysis and transplant were identified using diagnosis codes. In absence of UACR, a sensitive CKD definition would consider negative UA results as normal to mildly increased (KDIGO A1), trace to 1+ as moderately increased (KDIGO A2), and ≥2+ as severely increased (KDIGO A3). Sensitivity, specificity, and diagnostic accuracy of the CKD e-phenotype were 99%, 99%, and 98%, respectively. For dialysis sensitivity was 94% and specificity was 89%. For transplant, sensitivity was 97% and specificity was 91%. CONCLUSIONS: The CKD e-phenotype provides a pragmatic and accurate method for EHR-based identification of patients likely to have CKD.
引用
- Norton JM, Ali K, Jurkovitz CT, et al. Development and Validation of a Pragmatic Electronic Phenotype for CKD. Clin J Am Soc Nephrol. 2019. PMID: 31405830. doi:10.2215/CJN.00360119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。